Global Conjugate Vaccines Market Research Report 2019


    Table of Contents

      Executive Summary

        1 Conjugate Vaccines Market Overview

        • 1.1 Product Overview and Scope of Conjugate Vaccines
        • 1.2 Conjugate Vaccines Segment By type
          • 1.2.1 Global Conjugate Vaccines Production Growth Rate Comparison By type (2014-2025)
          • 1.2.2 Monovalent Conjugate Vaccines
          • 1.2.3 Multivalent Conjugate Vaccines
        • 1.3 Conjugate Vaccines Segment by Application
          • 1.3.1 Conjugate Vaccines Consumption Comparison by Application (2014-2025)
          • 1.3.2 Pediatrics
          • 1.3.3 Adults
        • 1.4 Global Conjugate Vaccines Market by Region
          • 1.4.1 Global Conjugate Vaccines Market Size Region
          • 1.4.2 North America Status and Prospect (2014-2025)
          • 1.4.3 Europe Status and Prospect (2014-2025)
          • 1.4.4 China Status and Prospect (2014-2025)
          • 1.4.5 Japan Status and Prospect (2014-2025)
        • 1.5 Global Conjugate Vaccines Market Size
          • 1.5.1 Global Conjugate Vaccines Revenue (2014-2025)
          • 1.5.2 Global Conjugate Vaccines Production (2014-2025)

        2 Global Conjugate Vaccines Market Competition by Manufacturers

        • 2.1 Global Conjugate Vaccines Production Market Share by Manufacturers (2014-2019)
        • 2.2 Global Conjugate Vaccines Revenue Share by Manufacturers (2014-2019)
        • 2.3 Global Conjugate Vaccines Average Price by Manufacturers (2014-2019)
        • 2.4 Manufacturers Conjugate Vaccines Production Sites, Area Served, Product Types
        • 2.5 Conjugate Vaccines Market Competitive Situation and Trends
          • 2.5.1 Conjugate Vaccines Market Concentration Rate
          • 2.5.2 Conjugate Vaccines Market Share of Top 3 and Top 5 Manufacturers
          • 2.5.3 Mergers & Acquisitions, Expansion

        3 Global Conjugate Vaccines Production Market Share by Regions

        • 3.1 Global Conjugate Vaccines Production Market Share by Regions
        • 3.2 Global Conjugate Vaccines Revenue Market Share by Regions (2014-2019)
        • 3.3 Global Conjugate Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.4 North America Conjugate Vaccines Production
          • 3.4.1 North America Conjugate Vaccines Production Growth Rate (2014-2019)
          • 3.4.2 North America Conjugate Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.5 Europe Conjugate Vaccines Production
          • 3.5.1 Europe Conjugate Vaccines Production Growth Rate (2014-2019)
          • 3.5.2 Europe Conjugate Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.6 China Conjugate Vaccines Production (2014-2019)
          • 3.6.1 China Conjugate Vaccines Production Growth Rate (2014-2019)
          • 3.6.2 China Conjugate Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.7 Japan Conjugate Vaccines Production (2014-2019)
          • 3.7.1 Japan Conjugate Vaccines Production Growth Rate (2014-2019)
          • 3.7.2 Japan Conjugate Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

        4 Global Conjugate Vaccines Consumption by Regions

        • 4.1 Global Conjugate Vaccines Consumption by Regions
        • 4.2 North America Conjugate Vaccines Consumption (2014-2019)
        • 4.3 Europe Conjugate Vaccines Consumption (2014-2019)
        • 4.4 China Conjugate Vaccines Consumption (2014-2019)
        • 4.5 Japan Conjugate Vaccines Consumption (2014-2019)

        5 Global Conjugate Vaccines Production, Revenue, Price Trend by Type

        • 5.1 Global Conjugate Vaccines Production Market Share by Type (2014-2019)
        • 5.2 Global Conjugate Vaccines Revenue Market Share by Type (2014-2019)
        • 5.3 Global Conjugate Vaccines Price by Type (2014-2019)
        • 5.4 Global Conjugate Vaccines Production Growth by Type (2014-2019)

        6 Global Conjugate Vaccines Market Analysis by Applications

        • 6.1 Global Conjugate Vaccines Consumption Market Share by Application (2014-2019)
        • 6.2 Global Conjugate Vaccines Consumption Growth Rate by Application (2014-2019)

        7 Company Profiles and Key Figures in Conjugate Vaccines Business

        • 7.1 Novartis
          • 7.1.1 Novartis Conjugate Vaccines Production Sites and Area Served
          • 7.1.2 Conjugate Vaccines Product Introduction, Application and Specification
          • 7.1.3 Novartis Conjugate Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.1.4 Main Business and Markets Served
        • 7.2 Neuron Biotech
          • 7.2.1 Neuron Biotech Conjugate Vaccines Production Sites and Area Served
          • 7.2.2 Conjugate Vaccines Product Introduction, Application and Specification
          • 7.2.3 Neuron Biotech Conjugate Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.2.4 Main Business and Markets Served
        • 7.3 Serum Institute of India
          • 7.3.1 Serum Institute of India Conjugate Vaccines Production Sites and Area Served
          • 7.3.2 Conjugate Vaccines Product Introduction, Application and Specification
          • 7.3.3 Serum Institute of India Conjugate Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.3.4 Main Business and Markets Served
        • 7.4 Pfizer
          • 7.4.1 Pfizer Conjugate Vaccines Production Sites and Area Served
          • 7.4.2 Conjugate Vaccines Product Introduction, Application and Specification
          • 7.4.3 Pfizer Conjugate Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.4.4 Main Business and Markets Served
        • 7.5 Sanofi Pasteur
          • 7.5.1 Sanofi Pasteur Conjugate Vaccines Production Sites and Area Served
          • 7.5.2 Conjugate Vaccines Product Introduction, Application and Specification
          • 7.5.3 Sanofi Pasteur Conjugate Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.5.4 Main Business and Markets Served
        • 7.6 Bharat Biotech
          • 7.6.1 Bharat Biotech Conjugate Vaccines Production Sites and Area Served
          • 7.6.2 Conjugate Vaccines Product Introduction, Application and Specification
          • 7.6.3 Bharat Biotech Conjugate Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.6.4 Main Business and Markets Served
        • 7.7 Biological
          • 7.7.1 Biological Conjugate Vaccines Production Sites and Area Served
          • 7.7.2 Conjugate Vaccines Product Introduction, Application and Specification
          • 7.7.3 Biological Conjugate Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.7.4 Main Business and Markets Served
        • 7.8 GlaxoSmithKline
          • 7.8.1 GlaxoSmithKline Conjugate Vaccines Production Sites and Area Served
          • 7.8.2 Conjugate Vaccines Product Introduction, Application and Specification
          • 7.8.3 GlaxoSmithKline Conjugate Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.8.4 Main Business and Markets Served
        • 7.9 Merck
          • 7.9.1 Merck Conjugate Vaccines Production Sites and Area Served
          • 7.9.2 Conjugate Vaccines Product Introduction, Application and Specification
          • 7.9.3 Merck Conjugate Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.9.4 Main Business and Markets Served
        • 7.10 CSL
          • 7.10.1 CSL Conjugate Vaccines Production Sites and Area Served
          • 7.10.2 Conjugate Vaccines Product Introduction, Application and Specification
          • 7.10.3 CSL Conjugate Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.10.4 Main Business and Markets Served

        8 Conjugate Vaccines Manufacturing Cost Analysis

        • 8.1 Conjugate Vaccines Key Raw Materials Analysis
          • 8.1.1 Key Raw Materials
          • 8.1.2 Price Trend of Key Raw Materials
          • 8.1.3 Key Suppliers of Raw Materials
        • 8.2 Proportion of Manufacturing Cost Structure
        • 8.3 Manufacturing Process Analysis of Conjugate Vaccines
        • 8.4 Conjugate Vaccines Industrial Chain Analysis

        9 Marketing Channel, Distributors and Customers

        • 9.1 Marketing Channel
          • 9.1.1 Direct Marketing
          • 9.1.2 Indirect Marketing
        • 9.2 Conjugate Vaccines Distributors List
        • 9.3 Conjugate Vaccines Customers

        10 Market Dynamics

        • 10.1 Market Trends
        • 10.2 Opportunities
        • 10.3 Market Drivers
        • 10.4 Challenges
        • 10.5 Influence Factors

        11 Global Conjugate Vaccines Market Forecast

        • 11.1 Global Conjugate Vaccines Production, Revenue Forecast
          • 11.1.1 Global Conjugate Vaccines Production Growth Rate Forecast (2019-2025)
          • 11.1.2 Global Conjugate Vaccines Revenue and Growth Rate Forecast (2019-2025)
          • 11.1.3 Global Conjugate Vaccines Price and Trend Forecast (2019-2025)
        • 11.2 Global Conjugate Vaccines Production Forecast by Regions (2019-2025)
          • 11.2.1 North America Conjugate Vaccines Production, Revenue Forecast (2019-2025)
          • 11.2.2 Europe Conjugate Vaccines Production, Revenue Forecast (2019-2025)
          • 11.2.3 China Conjugate Vaccines Production, Revenue Forecast (2019-2025)
          • 11.2.4 Japan Conjugate Vaccines Production, Revenue Forecast (2019-2025)
        • 11.3 Global Conjugate Vaccines Consumption Forecast by Regions (2019-2025)
          • 11.3.1 North America Conjugate Vaccines Consumption Forecast (2019-2025)
          • 11.3.2 Europe Conjugate Vaccines Consumption Forecast (2019-2025)
          • 11.3.3 China Conjugate Vaccines Consumption Forecast (2019-2025)
          • 11.3.4 Japan Conjugate Vaccines Consumption Forecast (2019-2025)
        • 11.4 Global Conjugate Vaccines Production, Revenue and Price Forecast by Type (2019-2025)
        • 11.5 Global Conjugate Vaccines Consumption Forecast by Application (2019-2025)

        12 Research Findings and Conclusion

          13 Methodology and Data Source

          • 13.1 Methodology/Research Approach
            • 13.1.1 Research Programs/Design
            • 13.1.2 Market Size Estimation
            • 13.1.3 Market Breakdown and Data Triangulation
          • 13.2 Data Source
            • 13.2.1 Secondary Sources
            • 13.2.2 Primary Sources
          • 13.3 Author List

          Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein.
          This protein has a key role in enhancing the immunogenic property of the polysaccharide. These vaccines are mainly used to immunize infants and children against invasive disease caused by Hib bacteria, H. influenzae, Streptococcus pneumoniae, and Neisseria meningitidis.
          The increase in use of conjugate vaccines for adults, rise in number of regulatory approvals for conjugate vaccines, growth in prevalence of diseases caused by microorganisms such as Streptococcus pneumoniae and Neisseria meningitidis, and technological advancements majorly drive the growth of the market. In contrast, low accessibility to vaccines in remote areas and complex production procedure of conjugate vaccine restraint the market growth.

          The global Conjugate Vaccines market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
          This report focuses on Conjugate Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Conjugate Vaccines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
          At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

          The following manufacturers are covered:
          Novartis
          Neuron Biotech
          Serum Institute of India
          Pfizer
          Sanofi Pasteur
          Bharat Biotech
          Biological
          GlaxoSmithKline
          Merck
          CSL

          Segment by Regions
          North America
          Europe
          China
          Japan

          Segment by Type
          By type
          Monovalent Conjugate Vaccines
          Multivalent Conjugate Vaccines
          By disease indication
          Pneumococcal
          Influenza
          Diphtheria Tetanus and Pertussis (DTP)
          Meningococcal
          Others
          By pathogen type
          Bacterial Conjugate Vaccine
          Viral Conjugate Vaccine
          Combination (Viral and Bacterial) Conjugate Vaccine

          Segment by Application
          Pediatrics
          Adults



          Summary:
          Conjugate Vaccines Market Research Report is Conjugate Vaccines Market Report. Get Conjugate Vaccines market research reports for Market Research, Analysis, Trends & Statistics. Latest Industry findings, analysis and Market Report on Conjugate Vaccines . Conjugate Vaccines Market Report is a syndicated market report to understand, Market Demand, Growth, trends analysis and Factor Influencing market in upcoming years.



          REPORT YOU MIGHT BE INTERESTED